Cogent Biosciences (COGT) Analyst & Key Data

Analyst Consensus

Buy13 analysts

Buy

Updated Sep 12, 2026

Total Analysts13

Buy

10

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$33.41

Median Target+39.99%

$46.77

Potential upside vs current price

DCF Value-99.07%

$0.31

Potential downside vs current price

Current Stock Price

$33.41

Median Target+39.99%

$46.77

Potential upside vs current price

DCF Value-99.07%

$0.31

Potential downside vs current price

Analyst Consensus

Buy13 analysts

Buy

Updated Sep 12, 2026

Total Analysts13

Buy

10

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$33.41

Median Target+39.99%

$46.77

Potential upside vs current price

DCF Value-99.07%

$0.31

Potential downside vs current price

Current Stock Price

$33.41

Median Target+39.99%

$46.77

Potential upside vs current price

DCF Value-99.07%

$0.31

Potential downside vs current price

Cogent Biosciences, Inc.